DermaKnowlogy ApS — Credit Rating and Financial Key Figures
CVR number: 10055318
Europavej 10, Purhus 8990 Fårup
info@dermapharm.dk
tel: 86477744
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -1 684.91 | - 559.16 | - 654.30 | - 920.15 | - 736.77 |
Total depreciation | - 107.04 | - 120.00 | -96.00 | -96.00 | -93.43 |
EBIT | -1 791.95 | - 679.16 | - 750.30 | -1 016.15 | - 830.20 |
Other financial expenses | - 116.93 | - 147.77 | - 164.45 | - 208.48 | - 210.38 |
Pre-tax profit | -1 908.88 | - 826.93 | - 914.75 | -1 224.63 | -1 040.59 |
Income taxes | 416.52 | 186.34 | 201.24 | 269.43 | 132.28 |
Net earnings | -1 492.36 | - 640.58 | - 713.51 | - 955.20 | - 908.30 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Development expenditure | 24.07 | 18.05 | 12.04 | 6.02 | |
Intangible rights | 367.27 | 281.69 | 196.11 | 110.53 | 24.96 |
Intangible assets total | 391.34 | 299.74 | 208.15 | 116.55 | 24.96 |
Machinery and equipment | 39.04 | 10.63 | 6.23 | 1.83 | |
Tangible assets total | 39.04 | 10.63 | 6.23 | 1.83 | |
Investments total | |||||
Long term receivables total | |||||
Raw materials and consumables | 34.59 | ||||
Finished products/goods | 42.11 | ||||
Inventories total | 34.59 | 42.11 | |||
Current trade debtors | 252.42 | 267.28 | 183.32 | 882.37 | 421.88 |
Prepayments and accrued income | 12.84 | 60.25 | |||
Current other receivables | 278.29 | 120.38 | 28.73 | 24.54 | |
Current deferred tax assets | 412.96 | 160.19 | 180.13 | 318.90 | 202.88 |
Short term receivables total | 956.51 | 427.47 | 544.08 | 1 230.00 | 649.31 |
Cash and bank deposits | 192.54 | 96.25 | 399.08 | 351.31 | 139.96 |
Cash and cash equivalents | 192.54 | 96.25 | 399.08 | 351.31 | 139.96 |
Balance sheet total (assets) | 1 614.01 | 834.10 | 1 157.54 | 1 699.70 | 856.34 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 126.00 | 126.00 | 126.00 | 126.00 | 126.00 |
Other reserves | 4.69 | ||||
Retained earnings | - 842.53 | -2 334.88 | -2 975.47 | -3 693.67 | -4 644.18 |
Profit of the financial year | -1 492.36 | - 640.58 | - 713.51 | - 955.20 | - 908.30 |
Shareholders equity total | -2 208.88 | -2 849.47 | -3 562.98 | -4 518.18 | -5 426.48 |
Provisions | 94.44 | 68.28 | 47.16 | ||
Non-current liabilities total | |||||
Current loans from credit institutions | 26.89 | 1.64 | 9.43 | ||
Current trade creditors | 133.55 | 55.07 | 165.58 | 70.21 | 60.26 |
Current owed to group member | 3 110.35 | 3 017.71 | 4 205.59 | 5 791.62 | 5 262.09 |
Other non-interest bearing current liabilities | 484.56 | 515.61 | 300.55 | 346.61 | 960.47 |
Current liabilities total | 3 728.46 | 3 615.29 | 4 673.35 | 6 217.88 | 6 282.82 |
Balance sheet total (liabilities) | 1 614.01 | 834.10 | 1 157.54 | 1 699.70 | 856.34 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.